Review of drug options for UTI bugs (that are commonly used in the UK):
Mapping on to the spectrum of the commonest UTI bugs we get this:
Item | Authors | DoI/link | Notes |
---|---|---|---|
UTI (lower): antimicrobial prescribing | NICE | https://www.nice.org.uk/guidance/ng109/resources/visual-summary-pdf-6544021069 | |
Pyelonephritis (acute): antimicrobial prescribing | NICE | https://www.nice.org.uk/guidance/ng111/resources/visual-summary-pdf-6544161037 | |
European Society of Clinical Microbiology and Infectious Diseases (ESCMID) guidelines for the treatment of infections caused by multidrug-resistant Gram-negative bacilli (endorsed by European society of intensive care medicine) | ESCMID | https://doi.org/10.1016/j.cmi.2021.11.025 | Europe advice for MDR gram-negatives |
Treatment of Ampicillin-Resistant Enterococcus faecium Urinary Tract Infections. | Richey et al. | PMID: 30766068 | Documented the treatment of Amp-R Enterococci with amoxicillin |
Urinary Tract Infections in Patients with Chronic Renal Insufficiency | Gilbert DN | 10.2215/CJN.01931105 | Brilliant paper on renal penetrance of various antibiotics. Table 1 in particular is worth memorising |
An infectious disease and pharmacokinetic perspective on oral antibiotic treatment of uncomplicated urinary tract infections due to multidrug-resistant Gram-negative uropathogens: the importance of urinary antibiotic concentrations and urinary pH | Cunha BA | 10.1007/s10096-016-2577-0 | Has information on doxycycline treatment of pseudomonas in urine. Also notes the effect of pH on antibiotic effectiveness |
Pharmacological properties of oral antibiotics for the treatment of uncomplicated urinary tract infections | Novelli A, Rosi E | 10.1080/1120009X.2017.1380357 | Nice general run-through of the PK of drugs commonly used for UTIs in europe |
Oral β-Lactam Antibiotics vs Fluoroquinolones or Trimethoprim-Sulfamethoxazole for Definitive Treatment of Enterobacterales Bacteremia From a Urine Source | Sutton JD et al | 10.1001/jamanetworkopen.2020.20166 | Comparison of FQ/Cotrim vs beta-lactams (Co-amoxiclav, Amoxicillin, Cephalexin, Cefpodoxime); composite outcome of 30d death or recurrent BSI; no difference. |